CA2117073A1 - Mutated growth factor receptor as a drug and its use for the treatment of cancer - Google Patents

Mutated growth factor receptor as a drug and its use for the treatment of cancer

Info

Publication number
CA2117073A1
CA2117073A1 CA 2117073 CA2117073A CA2117073A1 CA 2117073 A1 CA2117073 A1 CA 2117073A1 CA 2117073 CA2117073 CA 2117073 CA 2117073 A CA2117073 A CA 2117073A CA 2117073 A1 CA2117073 A1 CA 2117073A1
Authority
CA
Canada
Prior art keywords
receptor
pharmaceutical composition
composition according
egf
wild
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2117073
Other languages
English (en)
French (fr)
Inventor
Norbert Redemann
Axel Ullrich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2117073A1 publication Critical patent/CA2117073A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA 2117073 1991-09-05 1992-09-07 Mutated growth factor receptor as a drug and its use for the treatment of cancer Abandoned CA2117073A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4129533.1 1991-09-05
DE19914129533 DE4129533A1 (de) 1991-09-05 1991-09-05 Mutierter wachstumsfaktorrezeptor als arzneimittel und seine verwendung zur behandlung von krebs

Publications (1)

Publication Number Publication Date
CA2117073A1 true CA2117073A1 (en) 1993-03-18

Family

ID=6439926

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2117073 Abandoned CA2117073A1 (en) 1991-09-05 1992-09-07 Mutated growth factor receptor as a drug and its use for the treatment of cancer

Country Status (12)

Country Link
EP (1) EP0667899A1 (ja)
JP (1) JPH07502884A (ja)
CN (1) CN1071586A (ja)
AU (1) AU669857B2 (ja)
CA (1) CA2117073A1 (ja)
DE (1) DE4129533A1 (ja)
FI (1) FI941053A (ja)
MX (1) MX9205084A (ja)
NO (1) NO940778L (ja)
NZ (1) NZ244239A (ja)
PT (1) PT100844A (ja)
WO (1) WO1993005148A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465623B2 (en) 1995-05-02 2002-10-15 Garvan Institute Of Medical Research GDU, a novel signalling protein
AUPN274295A0 (en) * 1995-05-02 1995-05-25 Garvan Institute Of Medical Research GDU, a novel signalling protein
US6790614B1 (en) 1999-11-19 2004-09-14 Novartis Ag Selectable cell surface marker genes
CN104774931B (zh) 2004-03-31 2017-11-10 综合医院公司 测定癌症对表皮生长因子受体靶向性治疗反应性的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0325224B1 (en) * 1988-01-22 1996-07-31 ZymoGenetics, Inc. Methods of producing secreted receptor analogs
WO1990008160A1 (en) * 1989-01-20 1990-07-26 Imperial Cancer Research Technology Ltd. Growth factor receptor-like peptides without tyrosine-kinase activity
GB9001466D0 (en) * 1990-01-23 1990-03-21 Erba Carlo Spa Extracellular form of the human fibroblast growth factor receptor
EP0474727B1 (en) * 1989-05-19 1997-07-23 Genentech, Inc. Her2 extracellular domain
AU639726B2 (en) * 1989-09-08 1993-08-05 Duke University Structural alterations of the egf receptor gene in human gliomas

Also Published As

Publication number Publication date
CN1071586A (zh) 1993-05-05
FI941053A (fi) 1994-04-08
JPH07502884A (ja) 1995-03-30
MX9205084A (es) 1993-05-01
NO940778L (no) 1994-05-04
NZ244239A (en) 1995-07-26
DE4129533A1 (de) 1993-03-11
NO940778D0 (no) 1994-03-04
FI941053A0 (fi) 1994-03-04
WO1993005148A1 (de) 1993-03-18
AU669857B2 (en) 1996-06-27
EP0667899A1 (de) 1995-08-23
AU2518592A (en) 1993-04-05
PT100844A (pt) 1994-05-31

Similar Documents

Publication Publication Date Title
US5705157A (en) Methods of treating cancerous cells with anti-receptor antibodies
Shepard et al. Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinic
KR100373813B1 (ko) 이관능성단백질,그의제조및용도
Kokai et al. Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts
JP4620808B2 (ja) 突然変異上皮成長因子受容体を標的とする試薬および方法
DE69932600T2 (de) Zusammensetzungen und verfahren zur behandlung von tumoren
DE69630313T3 (de) Mit monoklonalem antikörper anti-her2 induzierte apoptosis
EP1469878B1 (en) Fgfr agonists
HU215581B (hu) Eljárás fibroblaszt növekedési faktor receptorok előállítására és terápiás alkalmazására
EA004793B1 (ru) Химерный белок растворимого рецептора интерлейкина-6/лиганда, его аналоги и способы применения
JPH05508550A (ja) 繊維芽細胞生育因子受容体
WO1997018241A1 (en) Inducing resistance to tumor growth with soluble igf-1 receptor
KR20170142995A (ko) 키메라 항원 수용체 및 키메라 항원 수용체가 발현된 t 세포
KR20160016725A (ko) 암 세포에 과발현되는 IL13Rα2에 특이적으로 결합하는 키메라 항원 수용체로 변형된 T 세포
USRE39789E1 (en) Tumor therapy
Lorenzi et al. FRAG1, a gene that potently activates fibroblast growth factor receptor by C-terminal fusion through chromosomal rearrangement.
Masuko et al. A murine monoclonal antibody that recognizes an extracellular domain of the human c‐erbB‐2 protooncogene product
CA2130089A1 (en) Protein compound, coding nucleotide sequences, producing cell line and uses thereof
US20060025362A1 (en) Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
US8703917B2 (en) Epidermal growth factor receptor variants and pharmaceutical compositions thereof
CA2117073A1 (en) Mutated growth factor receptor as a drug and its use for the treatment of cancer
CN115038719A (zh) 与cd300c抗原或其受体特异性结合的嵌合抗原受体
BR112021006254A2 (pt) composições e métodos relativos a células t¿d engenheiradas e não engenheiradas para tratamento de tumores sólidos
US8796421B2 (en) Human epidermal growth factor receptor variant lacking an exon
CA2217491A1 (en) Polynucleotide immunogenic agents

Legal Events

Date Code Title Description
FZDE Dead